Nishant Jain
Overview
Explore the profile of Nishant Jain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
724
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jain N, Sheikh M, Bajaj D, Townsend W, Krasuski R, Secemsky E, et al.
JACC Cardiovasc Interv
. 2023 Apr;
16(8):976-983.
PMID: 37100561
Background: Balloon pulmonary angioplasty (BPA) was introduced as a treatment modality for patients with inoperable, medically refractory chronic thromboembolic pulmonary hypertension decades ago; however, reports of high rates of pulmonary...
12.
Mendonza J, Reddy S, Dutta H, Makani V, Uppuluri V, Jain N, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Apr;
396(10):2651-2665.
PMID: 37097334
Neuroblastoma arises when immature neural precursor cells do not mature into specialized cells. Although retinoic acid (RA), a pro-differentiation agent, improves the survival of low-grade neuroblastoma, resistance to retinoic acid...
13.
Pamarthy D, Behera S, Swain S, Yadav S, Suresh S, Jain N, et al.
Drug Dev Res
. 2023 Apr;
84(5):861-887.
PMID: 37070554
Papillary thyroid carcinoma contributes to about 80% of the total thyroid cancer cases. BRAF is a frequently occurring mutation in PTCs. Although several BRAF inhibitors are available, many thyroid cancer...
14.
Sayyad Z, Kaveti S, Bhattacharjee D, Vedagiri D, Jain N, Swarup G
FEBS J
. 2023 Jan;
290(12):3110-3127.
PMID: 36705529
Optineurin/OPTN polymorphism, M98K is associated with normal tension glaucoma in certain populations, and genetic evidence shows its interaction with tumour necrosis factor-alpha (TNFα) polymorphism in causing glaucoma. Endoplasmic reticulum (ER)...
15.
Parisi D, Srivastava S, Parmar D, Strupat C, Brenner S, Walsh C, et al.
Health Policy Plan
. 2022 Dec;
38(3):289-300.
PMID: 36478057
The literature suggests that a first barrier towards accessing benefits of health insurance in low- and middle-income countries is lack of awareness of one's benefits. Yet, across settings and emerging...
16.
Chakrabarti M, Raut G, Jain N, Bhadra M
Biol Cell
. 2022 Dec;
115(2):e2200094.
PMID: 36453777
Background Information: Various types of stress initially induce a state of cardiac hypertrophy (CH) in the heart. But, persistent escalation of cardiac stress leads to progression from an adaptive physiological...
17.
Bhattacharjee D, Kaveti S, Jain N
Int J Biochem Cell Biol
. 2022 Nov;
154:106333.
PMID: 36400381
STAT3, an oncogene drives tumor growth and is associated with poor prognosis. However, small molecule-based STAT3 inhibitors were unsuccessful in clinics. Recently, STAT3 degraders that ubiquitinate STAT3 were found to...
18.
Chakrabarti M, Jain N, Bhadra M
Biochim Biophys Acta Gen Subj
. 2022 Nov;
1867(2):130268.
PMID: 36347344
No abstract available.
19.
Neill R, Neel A, Cardona C, Bishai D, Gupta S, Mohan D, et al.
Health Policy Plan
. 2022 Oct;
38(2):192-204.
PMID: 36222381
COVID-19 demanded urgent responses by all countries, with wide variations in the scope and sustainability of those responses. Scholarship on resilience has increasingly emphasized relational considerations such as norms and...
20.
Who Influences Cancer Conversations on Twitter?: A Comparative Surveillance of Cancer Communications
Jain N, Zachary I, Boren S
Stud Health Technol Inform
. 2022 Jun;
290:719-723.
PMID: 35673111
In this study, we used social network analysis to compare the Twitter social networks of top five cancers in the United States (as ranked by the CDC) to determine the...